Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Endocrinology and Metabolism|January 4, 2021
A Set of Markers Related to Viral Infection Has a Sex-sensitive Prognostic Value in Papillary Thyroid CarcinomaDongyi Wan, Xin Yang, Ganxun Li, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 29, 2025
Fusion model integrating multi-sequence MRI radiomics and habitat imaging for predicting pathological complete response in breast cancer treated with neoadjuvant therapyShaojie Xu, Yushi Ying, Qilan Hu, et al.
BMC Endocrine Disorders|May 19, 2023
Targeting the inward rectifier potassium channel 5.1 in thyroid cancer: artificial intelligence-facilitated molecular docking for drug discoveryXue Yang, Yonglin Wu, Shaojie Xu, et al.
Clinical and Translational Medicine|May 27, 2024
Targeting miR-31 represses tumourigenesis and dedifferentiation of BRAF<sup>V600E</sup>-associated thyroid carcinomaPeitao Zhang, Lizhao Guan, Wei Sun, et al.
The Journal of International Medical Research|July 25, 2024
Long-term survival in a patient with metastatic parathyroid carcinoma harboring an <i>EGFR</i> sensitizing mutation: a case reportYushi Ying, Hanning Li, Wenfei Xia, et al.
Nature Biotechnology|September 25, 2019
In vivo CRISPR screening in CD8 T cells with AAV-Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastomaLupeng Ye, Jonathan J Park, Matthew B Dong, et al.
Cell Proliferation|March 18, 2024
Directed differentiation of human embryonic stem cells into parathyroid cells and establishment of parathyroid organoidsGe Wang, Yaying Du, Xiaoqing Cui, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2021
CAR-T Cells Targeting TSHR Demonstrate Safety and Potent Preclinical Activity Against Differentiated Thyroid CancerHanning Li, Xiang Zhou, Ge Wang, et al.
Nature Biotechnology|January 26, 2023
Massively parallel knock-in engineering of human T cellsXiaoyun Dai, Jonathan J Park, Yaying Du, et al.
Cancer Discovery|September 5, 2020
CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint BlockadeGuangchuan Wang, Ryan D Chow, Lvyun Zhu, et al.
Pageof 4